Researchers from Queen's University Belfast and the University of Leeds, as part of a pan-European partnership called the European Cancer Concord (ECC) ®, have won the prestigious 2018 European Health Award.
This award honours initiatives that help tackle some of Europe's most pressing health challenges.
The award-winning project, entitled 'The European Cancer Patient's Bill of Rights: A Catalyst for Change and an empowerment tool for cancer patients across Europe' involves an equal partnership between cancer patients, healthcare professionals and cancer researchers.
Professor Mark Lawler, Chair in Translational Cancer Research at Queen's University Belfast and Vice President of ECC, today (Wednesday 3 October) received the award on behalf of the partnership during the opening ceremony of the European Health Forum Gastein, the premier European Health Policy Conference and an official event of the Austrian European Council Presidency.
One of the key outputs from the research has been the development of a 70:35 Vision, 70 per cent long term survival for all cancer patients across Europe by 2035.
"Our 70:35 Vision is built upon the pillars of cross border and interdisciplinary cooperation, sharing best practice and ensuring that research and innovation gets translated for the benefit of patients," explained Professor Peter Selby, Professor of Cancer Medicine at the University of Leeds and President of ECC. "This is a superb example of how cooperative European activities that involve sharing best practice between countries can result in top class prize-winning initiatives."
Professor Lawler commented: "Cancer knows no borders, so it is important that we work together to develop solutions that address cancer inequalities in all parts of Europe. I am immensely proud to be accepting this award, not only on behalf of our team who have worked together over the last five years on this initiative, but also on behalf of the millions of European citizens who are living with and beyond cancer, and experiencing cancer inequalities every single day of their lives."
Margaret Grayson, cancer survivor and Chairperson of the Northern Ireland Cancer Research Consumer Forum, said: "The news that the European Cancer Patient's Bill of Rights has received a top European award is wonderful. This collaborative initiative has patients absolutely at its centre. It is especially pleasing that Professor Lawler will be collecting this award at Gastein, given Northern Ireland's leadership role in the project."
In a joint statement, Professor Ian Greer, President and Vice-Chancellor of Queen's University Belfast and Professor Sir Alan Langlands, Vice-Chancellor of the University of Leeds welcomed the award: "The European Health Award is a prestigious award that recognises the very best of the European collaborative approach, involving over 60 stakeholders from 25 European countries, working together for the benefit of patients.
"We are immensely proud that an initiative, which was initiated at Queen's University in Northern Ireland, and where Leeds University and Queen's have demonstrated their strong leadership, has been recognised across Europe as a quality exemplar of best practice."
Working in close partnership with European patient organisations and professional societies has been a key part of the initiative.
"We at the European Cancer Patient Coalition (ECPC) are delighted to be part of this joint success," Lydia Makaroff, Director of the European Cancer Patient Coalition, added. "The ECPC has been a crucial partner in the European Cancer Patient's Bill of Rights since it was launched in the European Parliament on Word Cancer Day in 2014, and has worked tirelessly to find solutions to the disparities that cancer patients experience across Europe."
Speaking at the award ceremony, Professor Lawler said: "Cooperation is the key to this initiative. We need to compete, not against each other, but against our common enemy - Cancer."
Media inquiries to Zara McBrearty at Queen's University Communications Office on +44 (0)28 9097 2642/Mob: 07795676858 or email@example.com.